April 1, 2020
Shionogi said on March 31 that it has filed its anti-flu drug Xofluza (baloxavir marboxil) in Taiwan seeking an additional indication for the post-exposure prophylaxis of influenza virus infection in adults and children 12 years of age and older. The...read more